Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 667 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of Illinois Chicago Clear all

Conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases
Interventions: HTN Educational Video, Visual Echocardiogram Image Clips, Mobile Health and Remote BP monitoring, Post-Acute Care HTN Transition consultation (PACHT-c); Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 574 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence
Interventions: Bezlotoxumab, Standard CDI treatment; Biological · Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Nonalcoholic Steatohepatitis (NASH), Hepatic Steatosis
Interventions: Omega-3-acid ethyl esters (Lovaza), Placebo; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Sclerosis, Hypertension
Interventions: Home-based aerobic training; Behavioral
Lead sponsor: University of Massachusetts, Boston; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pancreatic Cancer, Pancreatic Adenocarcinoma, Duodenal Cancer, Distal Cholangiocarcinoma
Interventions: Hydrocortisone, Pancreatic resection; Drug · Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gender Dysphoria
Interventions: Mastectomy and chest masculinization; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 13 Years to 25 Years · Female only
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 3
States / cities: Chicago, Illinois

Conditions: Mild Cognitive Impairment, Subjective Memory Impairment
Interventions: fatty acid/flavonoid blend, Placebo; Dietary Supplement
Lead sponsor: University of East Anglia; Other
Eligibility: 55 Years and older
Enrollment: 259 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Obstructive Sleep Apnea
Interventions: Dronabinol; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Up to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Head and Neck Cancer, Stroke
Interventions: Not listed
Lead sponsor: University of Arkansas; Other
Eligibility: 21 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 2
States / cities: Urbana-Champaign, Illinois • Madison, Wisconsin

Conditions: Sarcopenia, High Blood Pressure, Hypertension
Interventions: progressive resistance training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 60 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type 2 Diabetes
Interventions: CGM plus telehealth, CGM only; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rockford, Illinois

Conditions: Acute Pancreatitis
Interventions: Dexcom Continuous Glucose Monitor (CGM); Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 13
States / cities: Los Angeles, California • Stanford, California • Gainesville, Florida + 8 more

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Resistance training, Aerobic training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 46 Years and older
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders
Interventions: Injectable extended-release buprenorphine, Sublingual buprenorphine-naloxone; Drug
Lead sponsor: Yih-Ing Hser; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 7
States / cities: El Dorado, Arkansas • Garberville, California • Gibson City, Illinois + 4 more

Conditions: Kidney Transplant
Interventions: Exercise Rehabilitation; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Chicago, Illinois • Oak Lawn, Illinois

Conditions: Atrial Fibrillation, Atrial Flutter, Heart Failure
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Tobacco Use Cessation
Interventions: Mi Quit Care; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Physical Activity
Interventions: Step 1: PA Monitor, Step 1: PA Monitor + Text, Step 2: PA Monitor with Calls, Step 2: PA Monitor with Meetings, Step 2: PA Monitor + Texts with Calls, Step 2: PA Monitor + Texts with Meetings, Step 3: PA Monitor; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 301 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Transcranial Direct Current Stimulation (tDCS), Sham tDCS + anodal tDCS; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Peripheral Arterial Disease, Peripheral Vascular Disease, Amputation, Lower Limb Amputation Knee, Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation Below Knee (Injury)
Interventions: Ischemic Conditioning Low - Sham Comparator, Ischemic Conditioning High - Active Comparator; Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hot Flashes, Hot Flushes, Vasomotor Symptoms
Interventions: Stellate Ganglion Block injection with bupivicaine, Saline; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 70 Years · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiac Disease, Mental Health Issue
Interventions: Rurality; Ethnicity; Exercise; Hopelessness; Other
Lead sponsor: Dordt University; Other
Eligibility: Not listed
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Sioux Falls, South Dakota

Conditions: Early-stage Breast Cancer, Hypoactive Sexual Desire Disorder, Hormone Receptor Positive Breast Carcinoma, Breast Cancer
Interventions: Aromatase Inhibitors, Bupropion, GnRH agonist; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Targeting of UnControlled Hypertension in Emergency Department

Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection

Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)

Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension

GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy

Chest Dysphoria in Transmasculine Spectrum Adolescents

The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial

DRonabinol Treatment of OSA

Real-Time Internet Evaluation of Swallowing

The Impact of a Resistance Training Intervention on Blood Pressure Control in Older Adults With Sarcopenia

Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients

The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery

Sodium Channel Splicing in Heart Failure Trial

Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)

Testing Adaptive Interventions to Improve Physical Activity for Sedentary Women

Remotely Supervised tDCS for Slowing ALS Disease Progression

The Effect of Ischemic Conditioning on Strength and Ambulation in Subjects with PAD

Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer

Exploring Potential Associations Between Rurality and Hopelessness in IHD Patients

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder